William J. Mcdaid
Manchester, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
The E3 ubiquitin ligase HUWE1 is required for KRAS-induced lung cancer.
Journal: Cell death & disease
Published: March 20, 2025
Mitochondrial metabolism determines chemotherapy sensitivity in colorectal cancer.
Journal: Nature metabolism
Published: March 27, 2024
The PI3K-AKT-mTOR axis persists as a therapeutic dependency in KRASG12D-driven non-small cell lung cancer.
Journal: Molecular cancer
Published: November 03, 2023
Hollow microneedle assisted intradermal delivery of hypericin lipid nanocapsules with light enabled photodynamic therapy against skin cancer.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: January 21, 2022
Clinical Positioning of the IAP Antagonist Tolinapant (ASTX660) in Colorectal Cancer.
Journal: Molecular cancer therapeutics
Published: December 09, 2020
Refined construction of antibody-targeted nanoparticles leads to superior antigen binding and enhanced delivery of an entrapped payload to pancreatic cancer cells.
Journal: Nanoscale
Published: May 22, 2020
DR5-targeted, chemotherapeutic drug-loaded nanoparticles induce apoptosis and tumor regression in pancreatic cancer in vivo models.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: February 25, 2020
Single-Domain Antibody-Functionalized pH-Responsive Amphiphilic Block Copolymer Nanoparticles for Epidermal Growth Factor Receptor Targeted Cancer Therapy.
Journal: ACS macro letters
Published: August 21, 2018
USP17 is required for trafficking and oncogenic signaling of mutant EGFR in NSCLC cells.
Journal: Cell communication and signaling : CCS
Published: August 03, 2018
Showing 1-12 of 12
Last Updated: 09/26/2026